Hideharu Tomita

1.7k total citations
26 papers, 1.5k citations indexed

About

Hideharu Tomita is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Surgery. According to data from OpenAlex, Hideharu Tomita has authored 26 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 10 papers in Physiology and 8 papers in Surgery. Recurrent topics in Hideharu Tomita's work include Nitric Oxide and Endothelin Effects (8 papers), Eicosanoids and Hypertension Pharmacology (6 papers) and Renin-Angiotensin System Studies (5 papers). Hideharu Tomita is often cited by papers focused on Nitric Oxide and Endothelin Effects (8 papers), Eicosanoids and Hypertension Pharmacology (6 papers) and Renin-Angiotensin System Studies (5 papers). Hideharu Tomita collaborates with scholars based in Japan, United States and Poland. Hideharu Tomita's co-authors include Hiroaki Shimokawa, Makoto Usui, Akira Takeshita, Kensuke Egashira, Masao Takemoto, Masamichi Koyanagi, Makoto Katoh, Junichi Sadoshima, Akihiro Takeshita and K Numaguchi and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Circulation Research.

In The Last Decade

Hideharu Tomita

25 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideharu Tomita Japan 17 825 520 436 221 169 26 1.5k
Jin-Jer Chen Taiwan 23 617 0.7× 675 1.3× 287 0.7× 236 1.1× 94 0.6× 53 1.7k
Pamela Harding United States 28 614 0.7× 698 1.3× 315 0.7× 144 0.7× 274 1.6× 62 1.8k
Makoto Katoh Japan 23 664 0.8× 540 1.0× 388 0.9× 411 1.9× 305 1.8× 88 1.8k
Thomas Quaschning Germany 23 633 0.8× 431 0.8× 674 1.5× 368 1.7× 384 2.3× 54 2.1k
Héctor De León United States 23 615 0.7× 689 1.3× 598 1.4× 375 1.7× 215 1.3× 49 2.0k
Hiromi Tasaki Japan 21 610 0.7× 359 0.7× 570 1.3× 395 1.8× 166 1.0× 67 1.5k
Jiyoong Kim Japan 27 1.0k 1.2× 601 1.2× 234 0.5× 249 1.1× 182 1.1× 68 1.9k
Sajoscha Sorrentino Germany 11 365 0.4× 462 0.9× 280 0.6× 343 1.6× 253 1.5× 17 1.3k
Yosuke Kayama Japan 16 869 1.1× 830 1.6× 299 0.7× 301 1.4× 339 2.0× 29 2.1k
Noriko Takahara Japan 15 363 0.4× 781 1.5× 512 1.2× 223 1.0× 372 2.2× 26 1.9k

Countries citing papers authored by Hideharu Tomita

Since Specialization
Citations

This map shows the geographic impact of Hideharu Tomita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideharu Tomita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideharu Tomita more than expected).

Fields of papers citing papers by Hideharu Tomita

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideharu Tomita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideharu Tomita. The network helps show where Hideharu Tomita may publish in the future.

Co-authorship network of co-authors of Hideharu Tomita

This figure shows the co-authorship network connecting the top 25 collaborators of Hideharu Tomita. A scholar is included among the top collaborators of Hideharu Tomita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideharu Tomita. Hideharu Tomita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tomita, Hideharu, Takuya Araki, Toshiaki Kadokami, et al.. (2016). Factors influencing trough and 90-minute plasma dabigatran etexilate concentrations among patients with non-valvular atrial fibrillation. Thrombosis Research. 145. 100–106. 8 indexed citations
2.
Suzuki, Mika, et al.. (2013). [A case of adult-onset type II citrullinemia in an elderly patient].. PubMed. 110(3). 432–40.
3.
Tomita, Hideharu, Toshiaki Kadokami, Natsumi Kawamura, et al.. (2013). Patient Factors against Stable Control of Warfarin Therapy for Japanese Non-valvular Atrial Fibrillation Patients. Thrombosis Research. 132(5). 537–542. 16 indexed citations
4.
Tomita, Hideharu, Hirofumi Yasui, Narikazu Boku, et al.. (2011). Leptomeningeal carcinomatosis associated with gastric cancer. International Journal of Clinical Oncology. 17(4). 361–366. 13 indexed citations
5.
Taniguchi, Hiroya, Kentaro Yamazaki, Narikazu Boku, et al.. (2011). Risk factors and clinical courses of chemoradiation-related arterio-esophageal fistula in esophageal cancer patients with clinical invasion of the aorta. International Journal of Clinical Oncology. 16(4). 359–365. 25 indexed citations
6.
Sakamoto, Takeshi, Hirofumi Yasui, Narikazu Boku, et al.. (2010). Comparison of combination chemotherapy with irinotecan and cisplatin regimen administered every 2 or 4 weeks in pretreated patients with unresectable or recurrent gastric cancer: retrospective analysis. International Journal of Clinical Oncology. 15(3). 287–293. 3 indexed citations
7.
Todaka, Akiko, Akira Fukutomi, Narikazu Boku, et al.. (2010). S-1 Monotherapy as Second-line Treatment for Advanced Pancreatic Cancer after Gemcitabine Failure. Japanese Journal of Clinical Oncology. 40(6). 567–572. 24 indexed citations
8.
Shimoyama, Rai, Hirofumi Yasui, Narikazu Boku, et al.. (2009). Weekly paclitaxel for heavily treated advanced or recurrent gastric cancer refractory to fluorouracil, irinotecan, and cisplatin. Gastric Cancer. 12(4). 206–211. 37 indexed citations
9.
Matsubayashi, Hiroyuki, Hideharu Tomita, Teiichi Sugiura, et al.. (2009). Autoimmune Pancreatitis without a Response to Steroid Therapy: A Case which Met Criteria after Withdrawal of Steroid. Internal Medicine. 48(24). 2087–2091. 7 indexed citations
10.
Hirotani, Shinichi, Peiyong Zhai, Hideharu Tomita, et al.. (2007). Inhibition of Glycogen Synthase Kinase 3β During Heart Failure Is Protective. Circulation Research. 101(11). 1164–1174. 97 indexed citations
11.
Hardt, Stefan E., Hideharu Tomita, Hugo A. Katus, & Junichi Sadoshima. (2004). Phosphorylation of Eukaryotic Translation Initiation Factor 2Bε by Glycogen Synthase Kinase-3β Regulates β-Adrenergic Cardiac Myocyte Hypertrophy. Circulation Research. 94(7). 926–935. 77 indexed citations
12.
13.
Sugano, Masahiro, Keiko Tsuchida, Hideharu Tomita, & Naoki Makino. (2002). Increased proliferation of endothelial cells with overexpression of soluble TNF-α receptor I gene. Atherosclerosis. 162(1). 77–84. 11 indexed citations
14.
Nakamura, Satoko, et al.. (2001). [Efficacy of pilsicainide for the long-term prevention of paroxysmal atrial fibrillation: analysis based on the time of onset].. PubMed. 38(4). 211–7. 3 indexed citations
15.
16.
Tomita, Hideharu, Kensuke Egashira, Yuichi Ohara, et al.. (1998). Early Induction of Transforming Growth Factor-β via Angiotensin II Type 1 Receptors Contributes to Cardiac Fibrosis Induced by Long-term Blockade of Nitric Oxide Synthesis in Rats. Hypertension. 32(2). 273–279. 169 indexed citations
17.
18.
Egashira, Kensuke, Makoto Usui, Hideharu Tomita, Makoto Katoh, & Akira Takeshita. (1997). Superoxide Anion is Involved in the Activation of Vascular Angiotensin-Converting Enzyme in Rats Induced by Chronic Inhibition of Nitric Oxide Synthesis. The Japanese Journal of Pharmacology. 75. 56–56. 2 indexed citations
19.
Ueno, Hiroo, Hideharu Tomita, Hisashi Yamamoto, et al.. (1995). Adenovirus-mediated arterial gene transfer does not require prior injury for submaximal gene expression.. PubMed. 2(5). 351–4. 17 indexed citations
20.
Tomita, Hideharu, Robert A. Brace, Cecilia Y. Cheung, & L. D. Longo. (1985). Vasopressin dose-response effects on fetal vascular pressures, heart rate, and blood volume. American Journal of Physiology-Heart and Circulatory Physiology. 249(5). H974–H980. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jin-Jer Chen Breakdown of academic impact, for papers by Pamela Harding Breakdown of academic impact, for papers by Makoto Katoh Breakdown of academic impact, for papers by Thomas Quaschning Breakdown of academic impact, for papers by Héctor De León Breakdown of academic impact, for papers by Hiromi Tasaki Breakdown of academic impact, for papers by Jiyoong Kim Breakdown of academic impact, for papers by Sajoscha Sorrentino Breakdown of academic impact, for papers by Yosuke Kayama Breakdown of academic impact, for papers by Noriko Takahara
Rankless by CCL
2026